News and Announcements
Cellmid Collaborates on Early Diagnosis of Colorectal Cancer
- Published July 29, 2013 9:57AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
- Cellmid signed collaboration agreement with Abcodia for testing midkine in longitudinal serum samples
- Abcodia has exclusive access to a unique collection of 5,000,000 serum samples
- Initially targeting validation of midkine as early marker of colorectal cancer
Sydney, Monday 29 July 2013: Cellmid Limited (ASX:CDY) signed a collaboration agreement with Abcodia Ltd, the UK biomaker validation company, for the testing of midkine (MK) in their collection of longitudinal serum samples using Cellmid’s MK-ELISA.
The initial objective of the collaboration to validate midkine as a useful marker for the screening and early diagnosis of colorectal cancer. Serum samples will be provided by Abcodia and testing will be carried out by Cellmid.
To read the full ASX announcement, please download the document below.
Company Updates
The Index Approach in Early-Stage Venture Capital: Reconsidered
The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]
The Future Is Now: The Evolution of Dealflow with Wholesale Investor
If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]
Investability of a Startup: A Comprehensive Guide for Angels and High-Net Worth Investors
Venturing into the Startup Scene Let’s dive into the intriguing world of startups. It’s a thrilling ride, isn’t it? Like finding a pearl in an ocean, spotting a promising startup amidst a sea of businesses is no easy task. This guide aims to light the way, focusing on the “The Investability of a Startup: 7 […]
Backed By Leading Investment Groups and Family Offices
